David Sidransky, Director at IMMUNE PHARMACEUTICALS INC (IMNP), bought 10,400 shares at $2.50 ($26K) on 2014-11-26, disclosed to the SEC on 2014-12-03.
Open-market purchase of $26k IMNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ADXS | SELL | 2016-08-10 | $342K | — | Filing → |